Literature DB >> 20099519

Resveratrol nanosuspensions for dermal application--production, characterization, and physical stability.

S Kobierski1, K Ofori-Kwakye, R H Müller, C M Keck.   

Abstract

Nanosuspensions of the anti-oxidant resveratrol (5%) were produced for dermal application. Production was performed by high pressure homogenization, applying 1.500 bar up to 30 cycles. Four nanosuspensions were investigated using the stabilizers Tween 80, Poloxamer 188, Plantacare 2000 and Inutec SP1, 1% and 2% respectively. The nanosuspensions were characterized regarding size (photon correlation spectroscopy, laser diffraction), zeta potential and crystallinity. Nanocrystal sizes were about 150 nm (Poloxamer, Plantacare) and about 200 nm (Tween, Inutec); no amorphous fraction could be detected in the nanocrystals. In a short-term stability study (30 days, room temperature), the nanosuspensions with 2% stabilizer proved to be either less stable or at least had no stability advantage over the 1% formulations. All formulations with 1% stabilizer were stable in the short-term study, Plantacare and Inutec showing best stabilization. The stabilization is attributed solely or mainly to steric stabilization, because the measured zeta potentials in the original dispersion media were close to zero (-1 to -5 mV, Tween, Poloxamer, Plantacare) or around -20 mV (Inutec).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20099519

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  11 in total

1.  Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin--a case study.

Authors:  Indrajit Ghosh; Bozena Michniak-Kohn
Journal:  AAPS PharmSciTech       Date:  2013-07-04       Impact factor: 3.246

2.  Celecoxib nanosuspension: single-step fabrication using a modified nanoprecipitation method and in vivo evaluation.

Authors:  Anju Malkani; Abhijit A Date; Darshana Hegde
Journal:  Drug Deliv Transl Res       Date:  2014-08       Impact factor: 4.617

Review 3.  The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges.

Authors:  Mary Ndiaye; Carol Philippe; Hasan Mukhtar; Nihal Ahmad
Journal:  Arch Biochem Biophys       Date:  2011-01-04       Impact factor: 4.013

Review 4.  Impact of nanotechnology in cancer: emphasis on nanochemoprevention.

Authors:  Imtiaz A Siddiqui; Vaqar M Adhami; Jean Christopher Chamcheu; Hasan Mukhtar
Journal:  Int J Nanomedicine       Date:  2012-02-02

Review 5.  Resveratrol as a therapeutic agent for Alzheimer's disease.

Authors:  Teng Ma; Meng-Shan Tan; Jin-Tai Yu; Lan Tan
Journal:  Biomed Res Int       Date:  2014-11-26       Impact factor: 3.411

Review 6.  Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability.

Authors:  Maria Rosa Gigliobianco; Cristina Casadidio; Roberta Censi; Piera Di Martino
Journal:  Pharmaceutics       Date:  2018-08-21       Impact factor: 6.321

7.  Preservation of rutin nanosuspensions without the use of preservatives.

Authors:  Pascal L Stahr; Cornelia M Keck
Journal:  Beilstein J Nanotechnol       Date:  2019-09-19       Impact factor: 3.649

Review 8.  Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease.

Authors:  Md Habibur Rahman; Rokeya Akter; Tanima Bhattacharya; Mohamed M Abdel-Daim; Saad Alkahtani; Mohammed W Arafah; Norah S Al-Johani; Norah M Alhoshani; Nora Alkeraishan; Alhanof Alhenaky; Omar H Abd-Elkader; Hesham R El-Seedi; Deepak Kaushik; Vineet Mittal
Journal:  Front Pharmacol       Date:  2020-12-30       Impact factor: 5.810

9.  Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents.

Authors:  Irfana Muqbil; Ashiq Masood; Fazlul H Sarkar; Ramzi M Mohammad; Asfar S Azmi
Journal:  Cancers (Basel)       Date:  2011-01-21       Impact factor: 6.639

10.  Nanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospects.

Authors:  Dhruba J Bharali; Imtiaz A Siddiqui; Vaqar M Adhami; Jean Christopher Chamcheu; Abdullah M Aldahmash; Hasan Mukhtar; Shaker A Mousa
Journal:  Cancers (Basel)       Date:  2011-10-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.